Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-21 @ 2:48 AM
Study NCT ID:
NCT03524092
Status:
COMPLETED
Last Update Posted:
2025-10-14
First Post:
2018-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
16823
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None